APMD

Conviction 0HealthcareScan · Fri, Oct 2, 2026

Apnimed, Inc. (APMD) closed at $21.54 (-4.46%) on Oct 2, 2026. RSI(14) 40, -33.8% from its 52-week high, -13.9% year to date. Sector: Healthcare · Biotechnology.

APMD$21.54-4.46%

ResistanceSupportVol 14Insider buy

Vol MA14 762.16K

Jul 31Aug 13Aug 26Sep 8Sep 21Oct 2

Apnimed, Inc.Biotechnology

Price21.54

Change-4.46%

Gap+2.57%

Rel volume0.34×

Avg volume609.55K

Avg $ vol15.72M

SMA 2025.06

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 29.08

RSI (14)40

MACD hist-0.37

MACD crossbear · 9d

Stoch %K / %D17 / 21

ADX (14)16

+DI / −DI15 / 24

RSI divergence—

MACD divergence—

ATR %12.94%

ADR %9.95%

52w high32.55

52w low21.09

From 52w high-33.84%

Above 52w low+2.11%

New 52w highNo

SqueezeOff

Bollinger width42.20%

%B0.17

Donchian pos16.65%

Donchian high30.22

Donchian low19.80

AVWAP (52w high)26.69

vs AVWAP high-19.30%

AVWAP (52w low)26.46

vs AVWAP low-18.61%

OBV trendFlat

Chaikin MF (20)-0.14

Today vs 20d0.34×

Avg vol (14d)762.16K

Avg vol (20d)609.55K

Avg $ vol (20d)15.72M

Market cap896.52M

RS Rating—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank15.4

1 week+2.11%

1 month-22.62%

3 months—

6 months—

1 year—

YTD-13.86%

P/E—

P/B-5.09

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq-0.23

Current5.19

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target50.33

Target upside133.71%

Analyst ratingBuy

Institutional—

Ent. value763.98M

Revenue12.08M

Net income125.94M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float20.46M

Float %49.1%

Short interest564.83K

Days to cover1.5d

Short volume33.1%

Squeeze score13 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.51

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank15.4 / 100

Group rank14 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance33.83

Support21.22

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APMD

All disclosures →

No recent disclosed trades by Congress in APMD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APMD

Insider	Side	Shares	Value	Traded	Filed
Alpha Wave Ventures GP, Ltd 10% owner · Common Stock · 2026-08-03	Convert	1M	—	2026-08-03	2026-08-05
Alpha Wave Ventures GP, Ltd 10% owner · Common Stock · 2026-08-03	Convert	534.21K	—	2026-08-03	2026-08-05
Alpha Wave Ventures GP, Ltd 10% owner · Common Stock · 2026-08-03	Convert	4.01M	—	2026-08-03	2026-08-05
Alpha Wave Ventures GP, Ltd 10% owner · Common Stock · 2026-08-03	Convert	1.51M	$20M	2026-08-03	2026-08-05
Alpha Wave Ventures GP, Ltd 10% owner · Series C-1 Preferred Stock · 2026-08-03	Convert	1.35M	—	2026-08-03	2026-08-05
Alpha Wave Ventures GP, Ltd 10% owner · Series C-2 Preferred Stock · 2026-08-03	Convert	720.65K	—	2026-08-03	2026-08-05
Alpha Wave Ventures GP, Ltd 10% owner · Series C-3 Preferred Stock · 2026-08-03	Convert	5.4M	—	2026-08-03	2026-08-05
Alpha Wave Ventures GP, Ltd 10% owner · Convertible Notes · 2026-08-03	Convert	—	—	2026-08-03	2026-08-05
Morningside Venture Investments Ltd 10% owner · Class A Common Stock · 2026-08-03	Convert	6.84M	—	2026-08-03	2026-08-05
Morningside Venture Investments Ltd 10% owner · Class A Common Stock · 2026-08-03	Dispose	6.84M	—	2026-08-03	2026-08-05

SEC filings

EDGAR filings in APMD · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

APMD

Recent news

Get daily signals & real-time alerts.